CXCL8 and systemic inflammatory response syndrome: Interestingly, addition of TNFα, IL-1β or IL-8 enhanced NETs formation and pre-treatment of SIRS patients’ plasma with their antibodies, significantly reduced NETs release and free radical generation, suggesting that neutralization of cytokines could be a useful approach for NETs mediated diseases.